← Eichor
Condition: Fontan Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fontan

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD
Phase N/A · 1 location(s) · Sisca Natalia Siagian · NCT07535203Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Hea
Phase N/A · 1 location(s) · Martin Schweiger · NCT07029230Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with
Phase N/A · 1 location(s) · Berlin Heart GmbH · NCT04782232The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Phase 4 · 2 location(s) · The University of Hong Kong · NCT07482943IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Phase 1 · 1 location(s) · Children's Mercy Hospital Kansas City · NCT06324396Fontan Fitness Trial
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT06918795Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Phase N/A · 11 location(s) · Leiden University Medical Center · NCT06932081Prospective Evaluation of Univentricular Hearts
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT05620030Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
Phase N/A · 1 location(s) · Children's Hospital Los Angeles · NCT07073612Fontan-Sprechstunde
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT05563376Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05213598Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Phase 3 · 40 location(s) · Mezzion Pharma Co. Ltd · NCT05918211Cholate Clearance in Fontan and Heart Failure
Phase N/A · 1 location(s) · HepQuant, LLC · NCT07009132CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
Phase 2 · 1 location(s) · Mayo Clinic · NCT06762964Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Phase 2 · 1 location(s) · Nationwide Children's Hospital · NCT04467671Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06735521Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
Phase 3 · 1 location(s) · Mayo Clinic · NCT05206955REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
NA · 2 location(s) · Stanford University · NCT06150950Fontan Circulation and Reproductive Health in a National Swedish Cohort
Phase N/A · 15 location(s) · Caroline Lilliecreutz · NCT06258382
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.